This video goes over the workup and management of non-muscle invasive bladder cancer (NMIBC). Daniel Reznicek, a urologist in Bellingham, WA goes over through the American Urological Association Guidelines on non-muscle invasive bladder cancer for patients. See the full guidelines here: https://www.auanet.org/guidelines/bla...

07:05 - Risk Category Descriptions
10:17 - Low Risk NMIBC Management
15:26 - Intermediate Risk NMIBC Management
19:15 - High Risk NMIBC Management

This video outlines criteria for low risk, intermediate risk, and high risk as outlined by the AUA guideline and goes through the surveillance and treatment options based on risk.

Other resources:
NCCN Patient Guidelines for Urothelial Cancer:
https://www.nccn.org/patients/guideli...
Urothelial Field Effect Study: https://clincancerres.aacrjournals.or...
Non-Muscle Invasive Bladder Cancer risk of progression:
https://www.ncbi.nlm.nih.gov/pmc/arti...
https://www.ncbi.nlm.nih.gov/pubmed/1...
Use of BCG therapy in NMIBC:
https://pubmed.ncbi.nlm.nih.gov/17604...